CJ Freshway Corporation (KOSDAQ:051500)

Ligand Pharmaceuticals Revenue

CJ Freshway had revenue of 798.64B KRW in the quarter ending March 31, 2025, with 9.19% growth. This brings the company's revenue in the last twelve months to 3.29T, up 5.91% year-over-year. In the year 2024, CJ Freshway had annual revenue of 3.22T with 4.90% growth.

• Revenue (ttm): 3,291.97B
• Revenue Growth: +5.91%
• P/S Ratio: 0.11
• Revenue / Employee: 428.31M
• Employees: 7,686
• Market Cap: 356.15B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3,224.78B	150.54B	4.90%
Dec 31, 2023	3,074.24B	326.55B	11.88%
Dec 31, 2022	2,747.69B	456.26B	19.91%
Dec 31, 2021	2,291.43B	-187.09B	-7.55%
Dec 31, 2020	2,478.53B	-576.55B	-18.87%